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Abstract
Background: The metabolic impact of participating in a diabetes camp is little known among children and
adolescents living with type 1 diabetes in sub-Saharan Africa. We aimed to assess the changes in glycemic control
and insulin doses in a group of children and adolescents living with type 1 diabetes in Cameroon during and after
camp attendance.
Methods: During a 5-day camp, we collected data on insulin doses, HbA1c, weight and blood glucose at least six
times per day in a group of children and adolescents living with type 1 diabetes. We compared the evolution of
these parameters 3 and 12 months after camp.
Results: Thirty-two campers completed the study. The mean age was 19 ± 2 years and the median duration of
diabetes was 2 [IQR: 1.8–5] years. The mean HbA1c was 7.9 ± 2.2 % and the mean insulin dose was 49 ± 20 units/day
upon arrival at camp. HbA1c dropped by 0.6 % after 12 months (p = 0.029). Despite the significant (p = 0.04) reduction
in insulin dose from 49 ± 20 to 44 ± 18 units/day at the end of camp, hypoglycemic episodes occurred in 26 campers.
However, the mean number of hypoglycemic episodes reduced from 1.32 (range: 0–4) on the first day, to 0.54 (range:
0–2) on the last day of camp (p = 0.006). Weight increased by 6 kg (p = 0.028) between 3 and 12 months after camp,
but insulin doses remained unchanged.
Conclusions: Attending camp for children and adolescents living with diabetes is associated with a significant
decrease in HbA1c twelve months after camp without changes in insulin doses. Including camps as an integral part
of type 1 diabetes management in children and adolescents in sub-Saharan Africa may yield some benefits.
Trial registration: ClinicalTrials.gov NCT02632032. Registered 4 December 2015.
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Background
Therapeutic education is central to the management of
diabetes, especially in children and adolescents [1]. To
be effective, therapeutic education should be individually
and collectively structured aiming to empower patients’
ability to manage their condition and to improve their
quality of life [2]. Camps for children and adolescents
living with diabetes represent an ideal environment for
education [3]. These camps are increasingly becoming
popular with nearly 46,000 children and adolescents
participating each year worldwide [4]. During camps, the
campers receive both theoretical and practical informa-
tion intended to improve their understanding of diabetes
[5]. Meals, insulin doses and physical activity programs
are developed in order to help campers to achieve better
glycemic control [6].
Several studies have shown the positive impact of
camps on the level of knowledge and social welfare of
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campers as well as their ability to self-support [7–10].
However, their metabolic impact is still debated and very
little is known on this subject in Sub-Saharan Africa.
Since October 2010, the “Changing Diabetes in Chil-
dren” (CDiC) project has structured the management sys-
tem of diabetes in children and adolescents in Cameroon.
Nine specialized clinics have been created all over the
country, and the project has organized training sessions
for 664 health personnel. Furthermore, campaigns have
been organized to raise awareness at local and national
level, and a national registry for diabetes in children has
also been launched. More importantly, free diabetes care
is being offered to all children and adolescents aged
18 years or less at enrolment into the project. The project
also organizes two annual camps for children and adoles-
cents living with diabetes. Unlike with previous editions,
the fifth camp organized in Yaoundé in July 2013 included
adolescents above 18 years. Also, it included only patients
from Yaoundé and surrounding areas. This rendered
follow-up after camp more feasible. The aim of this study
was to assess changes in glycemic control and insulin
doses in this group of campers, during the camp, as well
as 3 and 12 months after camp.
Methods
Participants and setting
In this study, we analyzed data obtained from children
and adolescents living with type 1 diabetes who attended
the diabetes camp of July 2013 and who came back for
follow up at the CDiC clinic of the Yaoundé Central
Hospital, 3 and 12 months later.
The CDiC project offers logistics and free medical care
to children living with type 1 diabetes in Cameroon, which
includes free medical consultations, insulin, syringes, a
glucose meter (Accu Check Active®, Roche Diagnostics
GmbH, Mannheim, Germany) glucose strips, HbA1c
monitoring every 3 months, collective therapeutic educa-
tion sessions every 3 months and a yearly screening for
complications. All children enrolled in the project have a
systematic medical visit every 3 months. During this visit,
clinical and biological assessments are done, as well as
adjustment of treatment where necessary. It also always
includes a therapeutic education session delivered by a
dedicated specialist nurse. All information obtained is re-
corded in the patient’s medical record. Many children also
consult outside systematic visits to collect material for
treatment or in the event of an emergency whether related
or not to diabetes. The forms of insulin available in the
project are regular insulin (Actrapid®), intermediate-acting
insulin (Insulatard®) and pre-mixed insulin (Mixtard 30®).
HbA1c is assessed by the in2it™ point-of-care system
(Bio-Rad Laboratories, Deeside, UK).
The CDiC project organizes a 5-day camp for about
50 children twice yearly. Participants are selected by the
health care personnel in charge of their care, based on
the availability of places and on the proximity to their
homes. Children aged less than 6 years, those with an
acute disease and those with incomplete recovery from a
previous illness are not allowed to camp.
Camp organization
A written informed consent was obtained from parents
or guardians before inclusion and a medical insurance
was contracted for campers and the camp staff. The
camp staff consisted of a pediatric endocrinologist, an adult
endocrinologist, 3 general physicians, 4 nurses, a dietician
and a sports coach. The leisure program during the camp
included educational workshops, games, sporting ac-
tivities, a visit to an animal reserve and dinner at a
local restaurant. Meals offered to the children attend-
ing the camp were prepared following the instructions
of the dietician.
Treatment protocols and insulin doses of each partici-
pant were maintained upon arrival. However, during the
camp and before every meal, the dose of insulin to be
injected was analyzed and eventually modified by the
physician based on the results of self-monitoring of blood
glucose, the quantity of carbohydrates to be ingested, and
the level of physical activity to be performed. Notwith-
standing, the treatment protocols could still be modified
for some children who were poorly controlled.
At the end of camp, a prescription was done for every
camper and an adjustment of doses was made based on
capillary blood glucose. Capillary blood glucose was
measured six times a day (before and 2 h after the 3
main daily meals), and as needed (before and after
any intense physical activity session, as well as in the
event of a symptoms suggestive of hypoglycemia). Fi-
nally, all information on each camper (injected insulin
doses, capillary blood glucose, HbA1c, weight and
eventual malaise) were recorded in a self-monitoring
booklet by the camper with supervision of a member
of camp staff.
Post-camp data collection
Campers were later routinely followed-up at the Yaoundé
CDiC clinic. Of the 46 patients who attended the camp,
only the 32 who came for both 3 and 12 months’ follow-
up visits were included in further analyses. We collected
data on age, gender, duration of diabetes, duration of
follow-up in the CDIC project, weight, insulin regimen
and insulin doses at the beginning, at 3 and 12 months
after camp, HbA1c at the beginning, at 3 and at 12 months
after camp, and the daily number of hypoglycemic epi-
sodes during camp. Good glycemic control was defined as
HbA1c <7.5 % and hypoglycemia as capillary blood glu-
cose < 70 mg/dl.
Dehayem et al. BMC Endocrine Disorders  (2016) 16:5 Page 2 of 6
Data analysis
Data were analyzed using the Statistical Package for
Social Sciences version 12 (SPSS Inc. Chicago, IL USA).
Results are presented as mean and standard deviation or
median [interquartile range] for continuous variables
and as count (percentage) for discrete variables. We
compared proportions by the Mc Nemar’s test for paired
data, means by repeated measure ANOVA, paired t test
or independent t test where appropriate and medians by
the Wilcoxon rank sum test. Where necessary, continu-
ous variables were categorized using the median as cut-
off. Analysis of factors associated with HbA1c level was
restricted to 3 months because of limitation associated
with data availability. A P-value < 0.05 was used to cha-
racterize statistically significant results.
Ethical considerations
Prior to enrolment in the CDiC project, a written informed
consent form was signed by parents or guardians authoriz-
ing the CDiC project in Cameroon to use the data obtained
for research. The CDiC project has also received approval
from the National Ethics Committee of Cameroon
(Authorization Nο 271/CNE/SE/2011) to carry out research
from data obtained in the project. This study received an
approval by the CDiC project steering committee.
Results
Baseline characteristics
Thirty-two campers were re-evaluated 3 and 12 months
after camp. None of them had ever attended a camp be-
fore. Table 1 describes the characteristics of the study
population (See also Additional file 1: Data of the 32
campers, and Additional file 2: Gender distribution, me-
dian age and location of campers). Most patients were
above 18 years of age, 13 were aged 12–18 years, and only
one patient was below 12 years. The majority (25/32) of
campers were treated with multiple daily injections of insu-
lin. There was no significant difference at baseline between
the 32 campers included in analysis, and the 14 with in-
complete follow-up data who were excluded, with regards
to the mean age, sex-ratio, median duration of diabetes
and median duration of follow-up in the CDiC project.
Outcomes during and after camp
The mean HbA1c decreased by 0.6 % after 12 months
(p = 0.029), and the number of patients who reached
HbA1c level < 7.5 % increased from 47 % at the begin-
ning of camp to 69 % 12 months later. The mean daily
insulin doses decreased by 6.4 % (p = 0.04) between the
beginning and the end of camp, and remained un-
changed 12 months after camp (Table 2). Out of the 32
campers, insulin doses were reduced in 18 (56 %), in-
creased in 6 (19 %) and maintained in 8 (25 %). The
average weight gain was 6 kg between 3 and 12 months
after camp (p = 0.028) (Table 2). During the 5 day-camp,
752 capillary glucose tests were performed in the 32
campers and 100 episodes of hypoglycemia were recor-
ded in 26 of them, with a maximum of 10 episodes in
one child. No severe hypoglycemia was recorded. The
mean number of hypoglycemic episodes reduced signi-
ficantly (p = 0.006) the last day [0.54 (range: 0–2)] of
camp when compared to the first day [1.32 (range: 0–4)]
(Table 2).
Factors associated with post-camp HbA1c levels
Diabetes duration less than 2 years (p = 0.041), visiting
the clinic more than 2 times during the 3 months of
post-camp follow up (p = 0.045), and monitoring blood
glucose more than twice daily (p = 0.005) were signifi-
cantly associated with lower HbA1c levels (Table 3). We
found no association between gender, age and time spent
in the CDiC project, and HbA1c levels (Table 3).
Discussion
In this study, we observed a significant decrease in
HbA1c in a group of sub-Saharan African children and
adolescents living with type 1 diabetes 12 months after
their first participation in a diabetes camp. We also found
a concomitant reduction in exogenous insulin needs and
an increase in their weight.
The impact of camps on the improvement of glycemic
control is controversial. Some studies have shown an
improvement in glycemic control including a significant
reduction in HbA1c and other glycated proteins after
camp [11, 14–17], whereas others have not [10–13].
Table 1 Baseline characteristics of campers and median
number clinic visits and capillary blood glucose/day 3 months
after camp (N = 32)
Variable Value
Gender (female/male) 13/19
Mean age (years) 19 ± 2
Mean weight (kg) 63 ± 12
Mean HbA1c (%) 7.9 ± 2.2
Mean insulin dose (units/day) 47 ± 20
Median [IQR] duration of diabetes (years) 2 [1.8–5]
Median [IQR] duration of follow-up in the
CDiC project (years)
1.8 [0.7–2.5]
Median [range] number of visits to the clinic
3 months after camp
2 [0–4]
Median [range] number of glycaemia/day
3 months after camp
3 [0–3]
Distribution of children according to the number
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A Thai study reported an initial significant drop in
HbA1c three months after camp, followed by an in-
crease at six months. In that study, the authors noted
a positive correlation between the number of daily ca-
pillary blood glucose, and the decrease in HbA1c
[16]. Other studies have reported a greater decrease
in HbA1c after camp in children with the worst pre-
camp glycemic control as well as in those regularly attend-
ing diabetes camps [11]. According to the authors the
improvement in glycemic control after camp would be
attributed to a better knowledge acquisition and diabetes
management skills during camp [4, 10, 11, 14–16]. Unlike
all the other studies, the decrease in HbA1c in our study
was more gradual and continuous, and was significant
only after 12 months.
We observed an association between the reduction of
HbA1c and the following factors: the number of capil-
lary blood glucose measurements done by the camper,
the number of hospital visits after camp and the dur-
ation of diabetes. There was no significant immediate
impact of the camp on glycemic control. However, a sig-
nificant improvement was observed only after a long
term follow up. The non-significant decrease in HbA1c
at three months probably reflects the fact that initial
HbA1c was not very high (7.9 %). The continuing decline
in HbA1c at 12 months in patients who carried out more
capillary blood glucose measurements or attended more
hospital visits indicates the importance of reinforcing the
knowledge and skills acquired during camp on the subse-
quent visits. Noteworthy, the same medical and nurse
personnel provided care to the campers both in camps
and in the hospital, and therefore were probably more
knowledgeable regarding social, psychological and emo-
tional aspects of the campers. This likely served to further
strengthen their education. The significant weight at three
months could be explained by an increase in physical ac-
tivity and diet control efforts in the campers after camp.
Hypoglycemia was very common at the beginning of
camp. The frequency was higher than that reported by
Maslow and Lobato in a literature review on diabetes
camps [11]. This was probably related to the increase in
physical activity and the healthier dietary measures
adapted to the nutritional needs of each camper while
maintaining the pre-camp insulin doses. To reduce the
frequency of hypoglycemia during camp, organizers
usually monitor and reduce the usual insulin doses of
campers by 10–30 % upon arrival [5, 10, 15, 18]. The
reduction in insulin doses alongside an appropriate
dietary plan permitted the significant reduction in the
frequency of hypoglycemia, which went down from
1.3 episodes per camper per day at the beginning to 0.5 at
the end of the camp.
Table 2 Outcomes at the end, and at 3 and 12 months after camp (N = 32)
Parameters Beginning of camp End of camp 3 months after camp 12 months after camp Overall p value
Mean HbA1c (%) 7.9 ± 2.2α - 7.6 ± 2.2 7.3 ± 1.9α 0.088*
Mean Insulin dose (unit/day) 47 ± 20β 44 ± 18β 44 ± 21 45 ± 21 0.39*
Mean Weight (kg) 63 ± 12 - 59 ± 16δ 65 ± 12δ 0.05*
HbA1c < 7.5 %, n/N (%) 15/32 (46.9) - 14/32 (43.7) 22/32 (68.8) 0.18Ω
Reduction of HbA1c, n/N (%)a / / 18/32 (56) 21/32 (66) 0.53
Reduction of insulin doses, n/N (%)b / 18/32 (56) 15/32 (47) / 0.59
*repeated measures ANOVA
αp = 0.029 between beginning of camp and 12 months after camp (paired t test)
βp = 0.04 between beginning and end of camp (paired t test)
δp = 0.028 between 3 months after camp and 12 months after camp (paired t test)
ΩProportion between the beginning and the end of camp (Mc Nemar test)
aReduction of HbA1c% if (HbA1c% at the beginning of camp – HbA1c% 3 or 12 months after camp) > 0
bReduction of insulin dose if (insulin dose at the beginning of camp – insulin dose at the end of camp or 3 months after camp) > 0
Table 3 Factors associated with HbA1c level 3 months after
camp
Median HbA1c [IQR] p-value*
Gender
Male (n = 19) 8.1 [6.9–8.6] 0.11
Female (n = 13) 6.7 [5.8–7.9]
Age
< 19 years (n = 14) 6.9 [5.3–8.4] 0.12
≥ 19 years (n = 18) 8.1 [6.7–8.7]
Duration of diabetes
≤ 2 years (n = 17) 5.9 [5.3–8.4] 0.041
> 2 years (n = 15) 8.1 [7.8–8.5]
Duration in CDiC project
≤ 1.8 years (n = 16) 6.4 [5.6–8.4] 0.073
> 1.8 years (n = 16) 8.1 [6.8–9.1]
Number of visits at the clinic
≤ 2 (n = 21) 8.1 [6.8–8.5] 0.045
> 2 (n = 11) 5.9 [5–8]
Number of glycaemia/day
≤ 2/day (n = 15) 8.4 [7.9–9.5] 0.005
> 2/day (n = 17) 6.0 [5.8–8]
*Wilcoxon rank sum test
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Our study has some limitations. The sample size was
small, although comparable to that of the majority of
quality prospective studies [5, 10, 15, 17]. The initial
number of campers was limited to ensure better moni-
toring and also to avoid accidents. In addition, 14 partic-
ipants were not reassessed after three months or
12 months and were excluded from the final analysis
which further reduced the size of our sample. The height
of campers at 3 and 12 months was not available for
most participants and could therefore limit the an-
thropometric evaluation. As another limitation, we used
a point-of-care device, which, although reliable, does not
give HbA1c values above 14 %; this may have underesti-
mated the overall mean HbA1c. However, this was very
limited because only one value was above 14 % at each
time point. The majority of campers lived in the city of
Yaoundé and could easily gain access to the clinic for
monitoring after the camp; the results may therefore not
be generalizable to the country and sub-Saharan Africa.
Despite these limitations, this study is, to the best of our
knowledge the first to assess the metabolic impact of
camps in children and adolescents with diabetes in sub-
Saharan Africa and has provided key messages. Skills
acquired during camp may not explain alone the im-
provements of glycemic control after camp, but may be
the triggering factor.
Conclusions
Our study indicates that camps can have a positive and
lasting metabolic impact on glycemic control in young
patients living with type 1 diabetes in sub-Saharan Africa.
This does not only require good organizational plan of the
camp, but also the frequent reassessment of these same
campers to reinforce and consolidate the acquired know-
ledge. The increase in the frequency of hypoglycemia
recorded at the beginning of the camp should lead to the
systematic reduction of insulin doses on arrival at camp,
especially in well-controlled campers.
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